A collaborative framework in which national and foreign actors converge allows the people of Uruguay access to a wide range of medicines, and the resilience of this structure has been shown during the COVID-19 pandemic, writes The Pharma Letter's Latin American correspondent.
Alfredo Antía, president of pharmaceutical industry trade group Asociación de Laboratorios Nacionales, said that, more widely, the country had made a success of its management of the pandemic, remaining one of the few countries in the region to keep the virus under control and to protect its older people, who make up a large part of the population.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze